Insider Screener
Real-time Form 4 Filtering Engine
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry (by SEC) | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-05 04:58 | 2025-03-03 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $7.96 | 118,013 | $939,608 | 577,361 | -17.0% |
| 2024-03-08 00:44 | 2024-03-06 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $5.60 | 34,811 | $194,942 | 495,928 | -6.6% |
| 2024-02-23 00:17 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $8.78 | 11,398 | $100,074 | 331,112 | -3.3% |
| 2023-03-07 00:29 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $8.94 | 11,296 | $100,986 | 331,214 | -3.3% |
| 2022-03-05 00:12 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | SALE | $12.01 | 3,060 | $36,751 | 6,610 | -31.6% |
| 2021-05-11 23:53 | 2021-05-11 | AUPH | Aurinia Pharmaceuticals Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | BUY | $9.74 | 1,000 | $9,740 | 1,000 | +100.0% |
| 2019-12-12 00:41 | 2019-12-10 | CERC | Avalo Therapeutics, Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | BUY | $2.85 | 2,598 | $7,398 | 48,777 | +5.6% |
| 2019-06-12 03:47 | 2019-06-10 | CERC | Avalo Therapeutics, Inc. | Miller Joseph M | Officer; Chief Financial Officer | Pharmaceutical Preparations | BUY | $2.85 | 1,179 | $3,357 | 46,179 | +2.6% |
Strategic Signal Filtering
Our screener allows you to cut through the noise of routine stock grants and small trades. By focusing on high-value transactions from C-suite executives (CEO/CFO), you can identify where the "Smart Money" is being deployed with maximum conviction.
Investing Without Illusions
Insider data is not a magic wand, but it is the most honest indicator available. While insiders sell for many reasons (taxes, personal needs), they generally buy for only one: they believe the stock price is undervalued. We provide the tools to track these skin-in-the-game moves.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.